{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T17:28:02Z","timestamp":1790962082260,"version":"4.1.0"},"reference-count":22,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2008,9,1]],"date-time":"2008-09-01T00:00:00Z","timestamp":1220227200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2008,9]]},"DOI":"10.1016\/j.clinthera.2008.09.010","type":"journal-article","created":{"date-parts":[[2008,10,6]],"date-time":"2008-10-06T08:24:48Z","timestamp":1223281488000},"page":"1726-1736","source":"Crossref","is-referenced-by-count":120,"title":["Compliance with antithrombotic prescribing guidelines for patients with atrial fibrillation\u2014A nationwide descriptive study in Taiwan"],"prefix":"10.1016","volume":"30","author":[{"given":"Li-Jen","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Hui","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng-Han","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Der-Chang","family":"Wung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ching-Lan","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yea-Huei","family":"Kao Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2008.09.010_bib1","doi-asserted-by":"crossref","first-page":"492","DOI":"10.7326\/0003-4819-131-7-199910050-00003","article-title":"Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: A meta-analysis","volume":"131","author":"Hart","year":"1999","journal-title":"Ann Intern Med"},{"issue":"Suppl 3","key":"10.1016\/j.clinthera.2008.09.010_bib2","doi-asserted-by":"crossref","first-page":"429S","DOI":"10.1378\/chest.126.3_suppl.429S","article-title":"Antithrombotic therapy in atrial fibrillation: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy","volume":"126","author":"Singer","year":"2004","journal-title":"Chest"},{"key":"10.1016\/j.clinthera.2008.09.010_bib3","doi-asserted-by":"crossref","first-page":"e257","DOI":"10.1161\/CIRCULATIONAHA.106.177292","article-title":"ACC\/AHA\/ESC 2006 guidelines for the management of patients with atrial fibrillation: A report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients with Atrial Fibrillation): Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society [published correction appears in Circulation. 2007;116:e138]","volume":"114","author":"Fuster","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.clinthera.2008.09.010_bib4","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/S0735-1097(01)01587-X","article-title":"ACC\/AHA\/ESC guidelines for the management of patients with atrial fibrillation: Executive summary. A report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients with Atrial Fibrillation): Developed in collaboration with the North American Society of Pacing and Electrophysiology","volume":"38","author":"Fuster","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.clinthera.2008.09.010_bib5","doi-asserted-by":"crossref","first-page":"927","DOI":"10.7326\/0003-4819-131-12-199912210-00004","article-title":"Warfarin use among ambulatory patients with nonvalvular atrial fibrillation: The Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) study","volume":"131","author":"Go","year":"1999","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.clinthera.2008.09.010_bib6","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1016\/j.jacc.2005.06.077","article-title":"Hospitalized patients with atrial fibrillation and a high risk of stroke are not being provided with adequate anticoagulation","volume":"46","author":"Waldo","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.clinthera.2008.09.010_bib7","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1093\/eurheartj\/ehl146","article-title":"Stroke prophylaxis in atrial fibrillation: Who gets it and who does not? Report from the Stockholm Cohort-study on Atrial Fibrillation (SCAF-study)","volume":"27","author":"Friberg","year":"2006","journal-title":"Eur Heart J"},{"key":"10.1016\/j.clinthera.2008.09.010_bib8","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0002-9343(98)00389-1","article-title":"Oral anticoagulation in patients with atrial fibrillation: Adherence with guidelines in an elderly cohort","volume":"106","author":"White","year":"1999","journal-title":"Am J Med"},{"key":"10.1016\/j.clinthera.2008.09.010_bib9","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1001\/archinte.167.3.246","article-title":"Newly detected atrial fibrillation and compliance with antithrombotic guidelines","volume":"167","author":"Glazer","year":"2007","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.clinthera.2008.09.010_bib10","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.amjcard.2005.09.086","article-title":"Patterns and predictors of warfarin use in patients with new-onset atrial fibrillation from the FRACTAL Registry","volume":"97","author":"Reynolds","year":"2006","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.clinthera.2008.09.010_bib11","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1001\/archinte.163.14.1705","article-title":"Predictors of warfarin use among Ohio Medicaid patients with new-onset nonvalvular atrial fibrillation","volume":"163","author":"Johnston","year":"2003","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.clinthera.2008.09.010_bib12","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1161\/01.STR.31.6.1217","article-title":"Warfarin for stroke prevention still underused in atrial fibrillation: Patterns of omission","volume":"31","author":"Cohen","year":"2000","journal-title":"Stroke"},{"key":"10.1016\/j.clinthera.2008.09.010_bib13","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1001\/archinte.160.1.41","article-title":"Why do patients with atrial fibrillation not receive warfarin?","volume":"160","author":"Bungard","year":"2000","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.clinthera.2008.09.010_bib14","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.1093\/eurheartj\/ehi505","article-title":"Atrial fibrillation management: A prospective survey in ESC member countries: The Euro Heart Survey on Atrial Fibrillation","volume":"26","author":"Nieuwlaat","year":"2005","journal-title":"Eur Heart J"},{"key":"10.1016\/j.clinthera.2008.09.010_bib15","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/j.1365-2796.2005.01512.x","article-title":"Frequency and effect of optimal anticoagulation before onset of ischaemic stroke in patients with known atrial fibrillation","volume":"258","author":"Indredavik","year":"2005","journal-title":"J Intern Med"},{"key":"10.1016\/j.clinthera.2008.09.010_bib16","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1046\/j.1440-6047.2001.00230.x","article-title":"Cardiovascular epidemiology in the Asia-Pacific region","volume":"10","author":"Khor","year":"2001","journal-title":"Asia Pac J Clin Nutr"},{"key":"10.1016\/j.clinthera.2008.09.010_bib18","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1159\/000086801","article-title":"The lowest effective intensity of prophylactic anticoagulation for patients with atrial fibrillation","volume":"20","author":"Cheung","year":"2005","journal-title":"Cerebrovasc Dis"},{"key":"10.1016\/j.clinthera.2008.09.010_bib19","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.2169\/internalmedicine.40.1183","article-title":"Optimal intensity of international normalized ratio in warfarin therapy for secondary prevention of stroke in patients with nonvalvular atrial fibrillation","volume":"40","author":"Yasaka","year":"2001","journal-title":"Intern Med"},{"key":"10.1016\/j.clinthera.2008.09.010_bib20","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1111\/j.1365-2125.2005.02361.x","article-title":"Is INR between 2.0 and 3.0 the optimal level for Chinese patients on warfarin therapy for moderate-intensity anticoagulation?","volume":"59","author":"You","year":"2005","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.clinthera.2008.09.010_bib21","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.thromres.2004.11.025","article-title":"Optimal INR for prevention of stroke and death in atrial fibrillation: A critical appraisal","volume":"117","author":"Od\u00e9n","year":"2006","journal-title":"Thromb Res"},{"key":"10.1016\/j.clinthera.2008.09.010_bib22","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1001\/jama.282.15.1458","article-title":"Why don't physicians follow clinical practice guidelines? A framework for improvement","volume":"282","author":"Cabana","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.clinthera.2008.09.010_bib23","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.1001\/jama.285.22.2864","article-title":"Validation of clinical classification schemes for predicting stroke: Results from the National Registry of Atrial Fibrillation","volume":"285","author":"Gage","year":"2001","journal-title":"JAMA"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291808003032?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291808003032?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,25]],"date-time":"2018-12-25T08:25:10Z","timestamp":1545726310000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291808003032"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,9]]},"references-count":22,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2008,9]]}},"alternative-id":["S0149291808003032"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2008.09.010","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2008,9]]}}}